Revolution Medicines (rvmd) Receives Fda’s “safe to Proceed” Letter for Daraxonrasib
Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the best performing healthcare stocks so far in 2026. Revolution Medicines, Inc. (NASDAQ:RVMD) announced on May 1 that the U.S Food and Drug Administration (FDA) issued a “safe to proceed” letter to the company, all